MERIDIAN BIOSCIENCE INC (CIK: 0000794172) EDGAR, Information, Filings... CompaniesBIO.Com

MERIDIAN BIOSCIENCE INC

Mailing address
3471 RIVER HILLS DRIVE, CINCINNATI, Ohio, 45244
Phone
5132713700
State location
Ohio
State of incorporation
Ohio
Fiscal year end
September 30
SIC
2835 - (CF Office: Office of Life Sciences) IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Filings
N/A

MERIDIAN BIOSCIENCE INC (CIK: 0000794172) is an American company incorporated in the state of Ohio. Head office is located at 3471 RIVER HILLS DR, CINCINNATI, Ohio, 45244. Work in the industry 2835 - (CF Office: Office of Life Sciences) IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES. MERIDIAN BIOSCIENCE INC is a public company and trade via Over-The-Counter (OTC).

Old names:

MERIDIAN DIAGNOSTICS INC from 1995-11-Oct to 2001-12-Feb

Owner	Filings	Transaction Date	Type of Owner
Smith Julie Diana	0001899659	Sep-16-2022	officer: Sr VP, Controller, PAO
Kitzmiller Andrew S.	0001795272	Feb-21-2022	officer: EVP & CFO
Serafini-Lamanna Tony	0001812602	Nov-05-2020	officer: Executive VP-Diagnostics
Bihl Anthony P III	0001432665	Jul-28-2020	director
Baldasare Bryan T	0001761920	Sep-16-2019	officer: Interim CFO & Chief Acctg Off
Williams Felicia	0001675737	Sep-20-2018	director
Rasmussen Eric S.	0001742235	Jun-04-2018	officer: EVP, Bus. Development/Strategy
WELTZIEN LOURDES	0001201184	Apr-24-2018	officer: EVP, Life Science
Kenny John P.	0001719325	Oct-09-2017	director, officer: Chief Executive Officer
Rice John McCune Jr.	0001714030	Aug-08-2017	director
Winslow Amy	0001670036	Mar-24-2016	officer: EVP, Pres & CEO of Magellan
McIlwraith John	0001650813	Aug-14-2015	director
Sazdanoff Catherine	0001650901	Aug-14-2015	director
Ellingwood Dwight E	0001614529	Jul-22-2014	director
Shaughnessy Michael C.	0001606181	Apr-22-2014	officer: EVP, Pres Meridian Global Dx
Elagin Vecheslav A	0001307505	Apr-21-2011	officer: VP, Research and Development
Calzavara Marco G.	0001517049	Apr-21-2011	officer: Pres & Managing Director, MBE
Johnson Marviette D.	0001519230	Apr-21-2011	officer: VP, Human Resources
Anderson James M.	0001468718	Aug-06-2009	director
Barnes Grady	0001425484	Nov-12-2008	officer: VP, Research & Development
READY ROBERT J	0000936975	Jan-18-2007	director
KREIDER GARY P	0001181954	Jan-18-2007	director
PHILLIPS DAVID	0001224661	Jan-18-2007	director
BUZARD JAMES	0001224660	Nov-16-2006	director
EBERLY RICHARD	0001224658	Nov-15-2006	officer: Exec VP, Pres Meridian Life Sc
INTERNO ANTONIO	0001224659	Nov-15-2006	officer: Pres, Managing Dir, MBE
ROLIH SUSAN	0001224665	Nov-15-2006	officer: VP, Reg Affairs and QA
LUEKE MELISSA	0001224663	Nov-03-2006	officer: VP, CFO
MOTTO WILLIAM J	0000940435	Sep-28-2006	director, officer: Chairman of the Board, CEO
Motto Todd W	0001341216	Sep-06-2006	officer: VP, Sales and Marketing
KOZAK KENNETH	0001224666	Aug-29-2006	officer: VP, Research & Development
KRAEUTLER JOHN A	0001224662	Jul-26-2006	director, officer: President and COO
BALDINI LAWRENCE	0001224664	Jul-17-2006	officer: Exec VP, Operations & IS
Motto Vivo Family Limited Partnership	0001305947	Aug-12-2004	10 percent owner
BALLISH GREGORY S	0001276478	Jan-12-2004	officer: VP, Sales and Marketing

Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by MERIDIAN BIOSCIENCE INC

Filings	Format	Description	Filed/Effective	File/Film Number
15-12G	Document	Notice of termination of registration of a class of securities under Section 12(g) Acc-no: 0001193125-23-035915 (34 Act) Size: KB	Feb-13-2023	000-14902 23619029
SC 13G/A	Document	Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0001104659-23-016461 (34 Act) Size: KB	Feb-09-2023	005-38201 23603809
10-Q	Document	Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0001193125-23-029272 (34 Act) Size: KB	Feb-09-2023	000-14902 23601231
EFFECT	Document	Acc-no: 9999999995-23-000267 (33 Act) Size: KB	Feb-03-2023	333-250878 23588232
EFFECT	Document	Acc-no: 9999999995-23-000266 (33 Act) Size: KB	Feb-03-2023	333-221794 23588227
EFFECT	Document	Acc-no: 9999999995-23-000263 (33 Act) Size: KB	Feb-03-2023	333-02613 23588225
EFFECT	Document	Acc-no: 9999999995-23-000265 (33 Act) Size: KB	Feb-03-2023	333-11077 23588221
EFFECT	Document	Acc-no: 9999999995-23-000264 (33 Act) Size: KB	Feb-03-2023	333-109139 23588217
SC 13D/A	Document	Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities Acc-no: 0001104659-23-010390 (34 Act) Size: KB	Feb-03-2023	005-38201 23585227
S-8 POS	Document	Post-effective amendment to a S-8 registration statement Acc-no: 0001193125-23-022599 (33 Act) Size: KB	Feb-02-2023	333-252538 23580233
S-8 POS	Document	Post-effective amendment to a S-8 registration statement Acc-no: 0001193125-23-022594 (33 Act) Size: KB	Feb-02-2023	333-179440 23580226
S-8 POS	Document	Post-effective amendment to a S-8 registration statement Acc-no: 0001193125-23-022588 (33 Act) Size: KB	Feb-02-2023	333-155703 23580221
S-8 POS	Document	Post-effective amendment to a S-8 registration statement Acc-no: 0001193125-23-022584 (33 Act) Size: KB	Feb-02-2023	333-122554 23580216
S-8 POS	Document	Post-effective amendment to a S-8 registration statement Acc-no: 0001193125-23-022579 (33 Act) Size: KB	Feb-02-2023	333-75312 23580197
S-8 POS	Document	Post-effective amendment to a S-8 registration statement Acc-no: 0001193125-23-022578 (33 Act) Size: KB	Feb-02-2023	333-74825 23580194
S-8 POS	Document	Post-effective amendment to a S-8 registration statement Acc-no: 0001193125-23-022573 (33 Act) Size: KB	Feb-02-2023	333-18979 23580166
S-8 POS	Document	Post-effective amendment to a S-8 registration statement Acc-no: 0001193125-23-022572 (33 Act) Size: KB	Feb-02-2023	033-65443 23580163
S-8 POS	Document	Post-effective amendment to a S-8 registration statement Acc-no: 0001193125-23-022568 (33 Act) Size: KB	Feb-02-2023	033-89214 23580155
S-8 POS	Document	Post-effective amendment to a S-8 registration statement Acc-no: 0001193125-23-022565 (33 Act) Size: KB	Feb-02-2023	033-78868 23580153
S-8 POS	Document	Post-effective amendment to a S-8 registration statement Acc-no: 0001193125-23-022562 (33 Act) Size: KB	Feb-02-2023	033-63260 23580145

Recent 20 filings. View all MERIDIAN BIOSCIENCE INC filings

Overall rating 5.0

Aug 22, 2022

Ryan Storey

Huge help thank you for your help .. y'all make it so much easier

Aug 22, 2022

Catherine

Thanks I look forward to using the product to improve my skin tone

Aug 22, 2022

Jean Bishop

Very good communication and delivery made within the timeframe I was advised of

MERIDIAN BIOSCIENCE INC overview
MERIDIAN BIOSCIENCE INC job
MERIDIAN BIOSCIENCE INC stock
MERIDIAN BIOSCIENCE INC ownership
MERIDIAN BIOSCIENCE INC CEO
MERIDIAN BIOSCIENCE INC documents

Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.